Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients wit (Q44375010)
Jump to navigation
Jump to search
scientific article published in April 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients wit |
scientific article published in April 2003 |
Statements
1 reference
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients wit (English)
1 reference
Hagop M Kantarjian
1 reference
Alessandra Ferrajoli
1 reference
Stefan Faderl
1 reference
Srdan Verstovsek
1 reference
William Wierda
1 reference
Jorge Cortes
1 reference
Guillermo Garcia-Manero
1 reference
Michael J Keating
1 reference
Maher Albitar
1 reference
Apostolia M Tsimberidou
1 reference
Francis J Giles
1 reference
Susan M O'Brien
1 reference
Deborah A Thomas
1 reference
Yesid Alvarado
1 reference
1 April 2003
1 reference
Identifiers
1 reference